The SMARCA2 gene helps control when other genes are switched on or off, which is especially important as the brain and body develop. This gene plays an important role in helping cells use DNA instructions at the right time. A harmful variant can cause Nicolaides-Baraitser syndrome, a genetic condition linked to developmental delay, limited speech, seizures, short stature, and changes in facial features, fingers, or hair. SMARCA2 is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes throughout the body. Some genes provide the information needed to produce proteins, which are the working parts of cells. Others mainly help control when certain processes take place, where they occur, and how strongly they run. Taken together, genes influence how your body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
SMARCA2Gene function
What if the gene works
The SMARCA2 gene helps cells switch other genes on and off by adjusting how tightly DNA is packed. This supports normal growth, brain development, and everyday cell repair.
Risk
What if the gene does not work
Variants that reduce the SMARCA2 gene's function can cause Nicolaides-Baraitser syndrome, affecting brain development, learning, speech, and often growth or feeding. Effects range from milder to more severe, which can influence when symptoms appear and whether seizures develop.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the SMARCA2 gene. In cancer research, the SMARCA2 gene is being studied as a possible drug target, especially in tumors with SMARCA4 loss, but this has not yet led to routine care.
Conditions associated with SMARCA2
Gene function
What if the gene works
Your cells constantly need to open some stretches of DNA and keep others less accessible. The SMARCA2 gene helps manage this process, so the right genes can be used at the right time. Understanding what the SMARCA2 gene does helps make sense of how cells choose their everyday instructions.
The SMARCA2 gene uses cell energy to reposition tightly packed DNA, making selected stretches easier to reach. This lets cells read needed instructions without changing the DNA code itself.
By adjusting DNA packing, the SMARCA2 gene helps switch many genes on or down as needed. This supports steady day to day cell activity and normal responses to signals.
Different cell types rely on different sets of active genes. The SMARCA2 gene helps maintain those patterns, so a skin cell, muscle cell, or nerve cell can keep doing its own job.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease-causing variants in the SMARCA2 gene do not simply switch the gene off. Many alter the energy-using part of the protein, so it works abnormally and may disrupt the cell’s control of how tightly DNA is packed and read. In SMARCA2 gene variants, milder changes may leave some activity, while more disruptive variants often disturb protein function more strongly. This can help explain why Nicolaides-Baraitser syndrome may vary in how early it appears and which features are more noticeable.
How variants are linked to conditions
A pathogenic variant in the SMARCA2 gene is a well-established cause of Nicolaides-Baraitser syndrome, a rare condition linked to developmental delay, limited speech, seizures, short stature, and distinctive fingers and facial features. This SMARCA2 gene variant is usually new in the person with the condition, though it can sometimes be inherited.
A variant is not necessarily a diagnosis
Variants are a routine feature of human biology and are widespread in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In other cases, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SMARCA2, risk is mainly determined by whether a disease-causing gene change is present; these changes usually happen new in the child, but risk is much higher if a parent carries the same change. There is not enough evidence to say lifestyle or environmental factors change the chance of developing the condition.
Inheritance of SMARCA2 variants
For Nicolaides-Baraitser syndrome, the SMARCA2 gene follows an autosomal dominant inheritance pattern. This means a person needs one disease-causing variant in the SMARCA2 gene to have the condition, and an affected parent can pass it to each child with a 50% chance. Many cases arise from a new, de novo variant, so the SMARCA2 inheritance pattern often appears in a child with no family history. A parent who carries the variant can pass it to sons and daughters equally.
What does my SMARCA2 result mean for my family?
For SMARCA2, the main family pattern is dominant, which means a parent, sibling, or child may also carry the same gene change. Close relatives may sometimes choose to discuss testing if the result is linked to Nicolaides-Baraitser syndrome. Many SMARCA2 changes happen for the first time in the affected person, so a parent does not always have the variant.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the SMARCA2 gene, genetic testing usually analyzes DNA from a blood sample or cheek swab. A lab reads the gene's code and compares it with the usual sequence to identify changes. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the SMARCA2 gene may be considered when a child has signs of a rare condition called Nicolaides-Baraitser syndrome, such as developmental delay, very limited speech, seizures, and changes in hair, face, fingers, or toes. It can also help when this condition seems to run in a family or a doctor is trying to confirm the cause.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it can tell you depends on the condition and on the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body functions over time. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than another. This is a common reason why some people get the expected benefit, while others may notice less effect or be more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences shape a person’s response to medications. It looks at relationships between genes and drugs to help explain why treatment effects can vary from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and individualized. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the SMARCA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about side effects, treatment changes, or other medicine concerns are best discussed with your doctor.
History
The SMARCA2 gene entered medical research through studies in the late 1980s and early 1990s, when scientists were mapping human genes involved in controlling how cells use DNA. It was soon recognized as part of a larger family of genes that drew attention in both developmental biology and cancer research. From these first observations, research expanded steadily. A major milestone came in 2011, when harmful variants in the SMARCA2 gene were identified as the cause of Nicolaides-Baraitser syndrome, linking years of laboratory work to a clearly defined inherited condition. That discovery helped clinicians connect a recognizable pattern of features with a specific genetic change. Since then, the gene has remained important in rare disease research and in studies of tumors that involve related genes.